Old Web
English
Sign In
Acemap
>
authorDetail
>
Steven Novick
Steven Novick
Bristol-Myers Squibb
Medicine
Internal medicine
Oncology
CAR T-cell therapy
Multiple myeloma
3
Papers
10
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
KarMMa-4: Idecabtagene vicleucel (ide-cel, bb2121), a BCMA-directed CAR T-cell therapy in high-risk newly diagnosed multiple myeloma.
2021
Journal of Clinical Oncology
Saad Z. Usmani
Jesus G. Berdeja
Anna Truppel-Hartmann
Yizhou Fei
Honeylet Wortman-Vayn
Suresh Shelat
Steven Novick
Nina Shah
Show All
Source
Cite
Save
Citations (1)
KarMMa-4: Idecabtagene Vicleucel (ide-cel, bb2121), a BCMA-Directed CAR T-Cell Therapy, in High-Risk Newly Diagnosed Multiple Myeloma
2020
Blood
Saad Z. Usmani
Jesus G. Berdeja
Anna Truppel-Hartmann
Marie-Laure Casadebaig
Honeylet Wortman-Vayn
Suresh Shelat
Steven Novick
Nina Shah
Show All
Source
Cite
Save
Citations (5)
KarMMa-3: A Phase 3 Study of Idecabtagene Vicleucel (ide-cel, bb2121), a BCMA-Directed CAR T Cell Therapy Vs Standard Regimens in Relapsed and Refractory Multiple Myeloma
2020
Blood
Michel Delforge
Rachid Baz
Michele Cavo
Natalie S. Callander
Armin Ghobadi
Paula Rodriguez-Otero
Maria-Victoria Mateos
Monica Massaro
Li Ding
Payal Patel
Gianfranco Pittari
Steven Novick
Sergio Giralt
Jesus G. Berdeja
Show All
Source
Cite
Save
Citations (4)
1